Pathogenetic studies of herpes simplex virus type 1 (HSV1) strains ANG and its mouse brainpassaged descendant ANG path revealed no difference in neurovirulence but a significant difference in neuroinvasiveness . Thus, both viruses induced a fatal encephalitis in mice after direct injection into the brain, but only ANG path induced lethal neurologic disease after inoculation on rear footpads . The difference in neuroinvasiveness is not related to the capacity to replicate in mouse neural tissues or mouse cells in general, but is specifically related to virus entry into the peripheral nervous system in the footpad. Marker rescue experiments in which ANG path genes were used to confer neuroinvasiveness on ANG indicated that the gene that codes for glycoprotein D (gD) is responsible for the phenotypic difference. Analyses of the gD genes by dideoxy-sequencing techniques identified a base difference in the coding sequences and predicted that the ANG gD gene codes for alanine (GCC codon) at amino acid position 84 in the open reading frame and the ANG path gD gene codes for glycine (GGC codon) at this site. Using these data, an oligonucleotide probe predicted to be specific for the ANG path gD gene was prepared, and in Southern blot analyses, this probe revealed that neuroinvasiveness-rescued agents had incorporated the base change seen in the ANG path gD gene. We conclude that HSV1 glycoprotein D functions to effect neuroinvasiveness and we discuss potential mechanisms that may be involved .
Summary
Pathogenetic studies of herpes simplex virus type 1 (HSV1) strains ANG and its mouse brainpassaged descendant ANG path revealed no difference in neurovirulence but a significant difference in neuroinvasiveness . Thus, both viruses induced a fatal encephalitis in mice after direct injection into the brain, but only ANG path induced lethal neurologic disease after inoculation on rear footpads . The difference in neuroinvasiveness is not related to the capacity to replicate in mouse neural tissues or mouse cells in general, but is specifically related to virus entry into the peripheral nervous system in the footpad. Marker rescue experiments in which ANG path genes were used to confer neuroinvasiveness on ANG indicated that the gene that codes for glycoprotein D (gD) is responsible for the phenotypic difference. Analyses of the gD genes by dideoxy-sequencing techniques identified a base difference in the coding sequences and predicted that the ANG gD gene codes for alanine (GCC codon) at amino acid position 84 in the open reading frame and the ANG path gD gene codes for glycine (GGC codon) at this site. Using these data, an oligonucleotide probe predicted to be specific for the ANG path gD gene was prepared, and in Southern blot analyses, this probe revealed that neuroinvasiveness-rescued agents had incorporated the base change seen in the ANG path gD gene. We conclude that HSV1 glycoprotein D functions to effect neuroinvasiveness and we discuss potential mechanisms that may be involved .
A definition of the specific interactions that take place between viruses and target organs is a critical goal in understanding viral pathogenesis. Powerful approaches employed in this area are those designed to identify and functionally characterize viral genes and gene products that are required for infection and replication in unique differentiated cell types in these organs (1, 2) . A target organ that has received considerable attention from virologists is the brain, and HSV is an agent that has well-appreciated but incompletely understood interactions with both the brain and the peripheral nervous system (3) . To understand the pathogenesis of HSV infections as they relate to the nervous system, three phases of the process must be understood. Thus, the mechanisms by which HSV (a) gains access to the nervous system (neuroinvasiveness), (b) causes disease in the central nervous system (neurovirulence), and (c) is maintained for extended periods in a nonreplicating form in neurons (latency) require definition. The focus of this investigation is identification and characterization of HSV genes that specifically effect neuroinvasiveness.
We show that HSV1 strain ANG (4, 5) demonstrates a phenotype specifically reduced for neuroinvasiveness. Thus, in contrast to most HSV strains, ANG is completely nonlethal for mice when inoculated on rear footpads, but it is fully neurovirulent when injected directly into the brain. By comparison, a brain-passaged derivative ofANG named ANG path (4, 5) causes lethal neurologic disease after both footpad inoculation (it is now neuroinvasive) and direct injection into the brain. The basis of this biologic difference is not related to the capacity to replicate in mouse neural tissues or mouse cells in general. Rather, tracing studies of virus infection in the mouse indicate that the difference is specifically related to the ability of the neuroinvasive ANG path agent to enter the peripheral nervous system in the footpad . Marker rescue experiments employing ANG path genes to confer neuroinvasiveness on ANG indicate that the gene that codes for glycoprotein D (gD)l is responsible for this difference . To establish unequivocally that gD is involved, the gD genes from both agents were sequenced, and a single base difference was identified . Analysis of the gD gene sequences predicts that the ANG gD gene codes for an alanine at position 84 in the mature protein, and the ANG path gD gene codes for a glycine at this position . Using these data, an oligonucleotide probe was prepared and employed in Southern blot procedures to show that neuroinvasive agents derived by marker rescue encode the same base change seen in the ANG path gD gene.
Materials and Methods
Virus Strains and Tissue Culture. HSV1 strains ANG and ANG path have been describedpreviously (4, 5) . The procedures for tissue culture of rabbit skin cells, preparation of primary mouse embryo fibroblasts, and infection, propagation, titration and plaque purification of viruses were described previously (6, 7) .
Mouse Inoculations and Virulence Testing. Outbred, 4-week old male Swiss-Webster mice (Simonsen Laboratories, Gilroy, CA and Harlan Sprague Dawley, Indianapolis, IN) were used, and equivalent results were obtained with mice from the two suppliers. Standard methods for intracranial inoculation (6, 7), scarified rear footpad inoculation with and without saline pre-treatment (8) , and quantitation of virulence were used (9) . DNA Cloning andAnalysis. Methods for DNA cloning, transformation, propagation and storage of bacteria, and mini-preparations of plasmid DNA have been described (10) . Restriction enzymes BamHI, BgIII, ClaI, EcoRl, HindIII, Hpal, NarI, Ncol, NruI, PstI, PvuII, Sall, Smal, and XbaI (Bethesda Research laboratories, Gaithersburg, MD); Asp718 and Nael (Boehringer Mannheim Biochemicals, Indianapolis, IN); AatII, AccI, and KpnI (New England Biolabs, Beverly, MA); and Ddel, Sacl, and SacII (Stratagene, La Jolla, CA) were used according to manufacturer's directions.
Transfection and In Vivo Selection ofRecombinants. The method for isolating virion and cloned DNA for transfection by isopycnic centrifugation has been described (11) . ANG was marker rescued by calcium phosphate transfection of rabbit skin cells with ANG DNA and a cloned DNA fragment as described previously, except that neuroinvasive recombinants were selected by inoculating virus onto saline-pretreated rear feet of mice and recovering virus from the brains of killed mice (6, 7, 12, 13) .
DNA Sequencing. Sanger dideoxy DNA sequencing was performed using Sequenase v2 .0 (US. Biochemical Corp., Cleveland, OH) according to the manufacturer's directions with [35 S]dATP (Amersham Corp., Arlington Heights, IL). Gel electrophoresis and autoradiography have been described previously (10) .
Oligonucleotide Primers and End-labeling. Ohgonucleotide primers were prepared by Dr. Dohn Glitz, Department of Biological Chemistry, UCLA . Primers were purified on a 20% acrylamide sequencing gel using published methods. Standard procedures for 5' end-labeling resulted in specific activities greater than 5 x 108 cpm/p,g (10) .
Southern Blot Analyses . Preparation of viral DNA for analytical purposes has been described (12) , and standard methods for agarose gel electrophoresis were used . Procedures for Southern blotting, hybridization and autoradiography have been described previously (10) .
Results
HSVI ANG and ANG Path Differ Specifically in Neuroinvasiveness. Comparative neuroinvasiveness of the two agents was established by inoculating virus on scarified rear footpads of mice and scoring for death resulting from encephalomyelitis. As shown in Table 1 , ANG path is lethal and demonstrates a median lethal dosage (LDso) of -105 PFU. In contrast, ANG is completely non-lethal for mice even when inoculated with as much as 10 8 PFU, the highest dosage of be attributed to a generalized lack ofvirulence for the nervous system . To further establish that the biologic difference is specific for neuroinvasiveness, virus replication was studied in mouse embryo fibroblasts (MEF) maintained in tissue culture at 38.5°C, the normal body temperature for mice. A low multiplicity of infection (0.001 PFU/cell) was used to approximate more closely infection in vivo. As seen in Fig. 1 , ANG and ANG path demonstrate similar replication profiles . As an extension ofthis experiment, virus replication in vivo following direct injection of 100 PFU into mouse brains was also studied. As shown in Fig. 2 , ANG and ANG path replicate to similar levels in the mouse brain through 84 h. After 84 h, all mice are dead. These results indicate that ANG is not restricted for replication in mouse neural tissues in vivo and, when taken with those obtained in vitro, show that ANG's inability to kill after footpad inoculation is not attributable to a general defect for replication in mouse cells.
Anatomic Site ofRestriction ofANG Neuroinvasiveness. To determine where in the neural route from the footpad to brain 
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Izumi and Stevens the ANG invasion is restricted, we inoculated mice with 106 PFU on scarified rear footpads. Feet, sciatic nerves, lumbosacxal spinal ganglia, dorsal roots, spinal cords, and brains were removed at various intervals after inoculation, and these tissues were titrated for virus content . In the footpad (Fig. 3 A) , ANG is somewhat restricted for replication compared with ANG path. In the nervous tissues that were examined ( Fig.  3 , B-F), ANG demonstrates restricted replication compared with ANG path, the difference between the replication of ANG and ANG path is more pronounced in more central nervous tissues, and no ANG is detected in the brain. These results indicate that the ANG invasion is restricted in the footpad, and this restriction may lead to reduced amounts of ANG in neural tissues.
Although the results just presented indicated that the ANG invasion is restricted in the footpad, the exact nature of the neuroinvasiveness defect might be related to restricted replication in some cell type unique to the footpad or it could be due to reduced entry into the nervous system in the footpad . To investigate this further, we inoculated mice on rear footpads with 108 PFU of ANG and 106 PFU of ANG path and assessed virus invasion into the nervous system . In the footpad 8 a . HSV in tissues along the neural route of infection from the footpad to the brain after rear footpad inoculation with 108 PFU of ANG and 106 PFU of ANG path . On the days indicated, three mice were killed, feet (A), sciatic nerves (B), lumbosacral spinal ganglia (G), dorsal roots (D), spinal cords (E), and brains (F) were removed, and all tissues were frozen at -70°C. Once all samples were accumulated, tissues were homogenized as 10% (wt/vol) suspensions and centrifuged 5 min at 3,000 g. The resulting supernatant was titrated for virus. ANG (Q), ANG path (A). Dashed line indicates limit of assay sensitivity.
Herpes Simplex Virus Type 1 Neuroinvasiveness (Fig. 4 A) , there is more ANG than ANG path until day 3, at which time both agents reach 4 x 10°PFU/foot . On days 4 and 5, there is more ANG path than ANG, and by day 9 neither virus is recovered in the footpad. Clearly, the cumulative amounts of ANG and ANG path in the footpad are similar. And there is more ANG in the footpad during the first 3 d of infection . Nevertheless, in the nervous tissues that were examined (Fig. 4 , B-E), ANG demonstrates restricted replication compared with ANG path, the difference between the replication of ANG and ANG path is more pronounced in more central nervous tissues, and no ANG is detected in the brain. From these results, we conclude that a defect in ANG leads to reduced virus entry into the nervous system in the footpad . In addition, there may be a restriction related to entry into the central nervous system . Identification of the Genetic Defect in ANG. The general strategy of marker rescue has been described previously (7, 13) . In brief, ANG DNA is transfected into cells with cloned genes from ANG path. Virus recombinants are generated and analyzed by inoculation on mouse rear footpads. If at least one mouse out of a group offour is killed, the co-transfection culture is scored positive and is presumed to contain neuroinvasive recombinant agents. Initially, cloned XbaI and EcoRI fragments spanning the entire HSV genome were used, and the results (data not shown) indicated that the ANG path EcoRI h fragment (0.867-0 .963 map units) conferred neuroinvasiveness on ANG. Virus from cell cultures transfected with ANG DNA and its own EcoRI h fragment never killed mice.
Viruses recovered from the brains of mice killed by infection with ANG path EcoRI h and ANG DNA co-transfection cultures were plaque-purified and analyzed for neuroinvasiveness. As shown in Table 2 , these agents (SAP130 3.1, 6 12 6.1, 8 12 C4, and 9 8 A2) demonstrate LDsos of ti106 PFU, ANG path was N10 times more lethal (LDso of N10 5 PFU), and ANG was at least 100 times less lethal (LDso > 108 PFU). To demonstrate that these results were not attributable to transfection-induced artifact (14), we carefully tested the genetic stability of ANG. Mouse footpads were injected subcutaneously with 10% (wt/vol) sodium chloride, a procedure that enhances susceptibility to infection (15), before they were inoculated with virus generated by ANG DNA cotrinsfection with its own EcoRI h fragment . On day 6, the approximate day mice inoculated with virus generated by ANG path EcoRI h DNA and ANG DNA co-transfections had died, mice were killed. 16 separate viruses were recovered from brains, stocks were made in cell culture, and viruses were analyzed by inoculating 108 PFU on rear footpads . None of these virus isolates induced a lethal infection . These results indicate that the neuroinvasiveness defect in ANG is not altered by transfection per se but by the genes included in the transfection .
We next attempted to precisely localize the defect in ANG with subclones of the ANG path EcoRI h fragment . EcoRI h DNA was subcloned into three pieces, KpnI f (the middle fragment) and EcoRI h del f (the end fragments), and these were used in marker rescue experiments. The results (Fig.  5) indicate that the KpnI f fragment rescues ANG for neuroinvasiveness. Although the EcoRI h del f fragment gave a positive result in one experiment, we were unable to repeat this, and we attribute this one individual result to a group of mice that was uniquely susceptible to infection (the KpnI f fragment was positive in seven of nine of the cultures tested in this experiment) .
The ANG path KpnI f fragment was then divided into smaller fragments, KpnI f/HindIII n, BamHI j, and KpnI f/HindIII g. In three experiments (Fig. 6) , the BamHI j fragment and the KpnI f/HindIII g fragment conferred neuroinvasiveness on ANG, so attention was focused on the three open reading frames (ORFs) that are encoded in the region 
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Izumi and Stevens shared by the BamHI j and KpnI f/HindIII g fragments. Those three ORFs code for glycoprotein D or US6, glycoprotein I or US7, and glycoprotein E or US8 . A 2.4-kb HindIII-SacI fragment comprising the ORFs for glycoprotein D (gD) and glycoprotein I (gl), a 1 .6-kb NaeI-DdeI clone encompassing the gl ORF, and a 2.1-kb DdeI-Sall fragment spanning the ORF for glycoprotein E (gE) were used in marker rescue experiments . As shown in Fig. 7 , the HindIII-SacI fragment comprising the gD and gI ORFs and the DdeI-Sall fragment encoding the gE ORF conferred neuroinvasiveness on ANG.
Since the fragment that spans the ORFs for both gD and gl but not the 1 .6-kb NaeI-DdeI clone encompassing the gI ORF was positive, the gD ORF was implicated as a gene responsible for the neuroinvasiveness defect in ANG. To examine this, marker rescue experiments using a 1.4-kb HindIIINruI fragment that encompasses the gD ORF were performed . As shown in Fig. 7 , the ANG path HindIII-NruI fragment rescued ANG for neuroinvasiveness. Here, we were not able to repeat the positive result obtained earlier with the 2.1-kb DdeI-SaII fragment that spans the ORF for gE and have not pursued this aspect further. The ANG path 1.4-kb HindIII-NruI fragment was compared with the homologous ANG fragment and, as summarized in Fig. 8 , the ANG path but not the ANG clone conferred neuroinvasiveness on ANG . These data implicated the gD gene with the neuroinvasiveness defect in ANG, but it was still possible that sequences that encode the promoter 
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Herpes Simplex Virus Type 1 Neuroinvasiveness of transcription for the gI gene were responsible . To examine this possibility, -400 by were removed from one end of the 1 .4-kb HindIII-NruI fragments by cleavage with NarI. The resulting 1.0-kb HindIIl-NarI fragments span -80% of the gD open reading frame and stop -340 by upstream of the 5' end of the gI transcript . As seen in Fig. 8 , the ANG path HindIII-NarI fragment but not the ANG clone rescued ANG for neuroinvasiveness . As the cumulative data indicate, decreasing'the length of DNA fragments employed decreases the relative ratio of positive transfections . A likely reason for this result is the decreased efficiency of recombination which is known to take place for markers present in shorter DNA fragments . To determine whether this was the case, we attempted to enhance rescue of the neuroinvasiveness defect in ANG by ligating a 5.6-kb ANG HindIII n fragment (0 .878-0.914 map units) to the 1 .0-kb ANG path HindIII-NarI fragment (0.914-0 .921 map units) . As shown in Table 3 , three of six and two of six cultures generated by co-transfecting the expanded ANG path gD clone with ANG DNA rescued ANG for neuroinvasiveness. As Table 3 also indicates, a similarly expanded ANG HindlII n plus ANG HindIII-NarI fragment did not kill mice (zero o£ six and zero of six cultures were positive) . Clearly, this maneuver restores the efficiency of rescue of ANG neuroinvasiveness to a level (42%) comparable to the 37% obtained with the similarly sized ANG path HindIII g/KpnI f fragment described earlier (Fig. 6 ) .
Based upon this and the other marker resuce analyses described, we conclude that a significant defect in the virus ANG which restricts neuroinvasiveness maps within the 1 .0 kb HindIII-NarI fragment which codes for most of the open reading frame of glycoprotein D . Site of Defect in the ANG gD Gene. To determine where in the gene which codes for gD the alteration occurred, two approaches were taken . First, the ANG and ANG path gD genes were sequenced . Second, viral isolates recovered from the brains of mice that were killed by infection in marker rescue experiments were analyzed both phenotypically and TAA GGT CTC TTT TGT GM GM CGT TOO GGT I ATO~G   L  GOG  Y ALA   Sipnel Sequence  ALA ARG LEU GLY ALA VAL ILE LEU PHE VAL VAL ILE VAL GLY LEU  ATT TTG TTT GTC OTC ATA GM GGI; TC  1  10  HIS GLY VAL ARG  (25) I LYS TYR ALA LEU ALA ASP ALA SER LEU LYS   CAT OOG GTC OW GOC AAA TAT OGG TTG GCG GAT GOC TCT CTC AAG  25  MET ALA ASP PRO ASN CGC PHE ARG GLY LYS ASP LEU PRO VAL PRO  ATG GOC GAC CCC AAT OW TTT CGC GOO AAA GAC CTT COG GTC number 84 in the mature protein and ANG path encodes glycine (GGC codon) at this same site (Fig. 9 ) . Phenotypic analysis (Table 4 ) of plaque-purified viruses recovered from the brains of mice killed by infection with virus generated by ANG DNA co-transfection with the ANG path HindIII-NarI fragment indicates these agents are lethal for mice following footpad inoculation . These agents (33LB1, Figure 10 . Duplicate Southern blots of BamHI generated fragments of ANG path, ANG, and three neuroinvasive viruses 33LB1, 33LC2, and 3901D derived from co-transfections of ANG DNA with the 1 .0-kb ANG path HindIII/NarI fragment that comprises gD. These blots were hybridized with 3 2P end-labeled oligonucleotide primer 5'CGCGGGGGCTCCGAAGAC3' which is predicted to be specific for ANG path gD, and washed at 60°C or 65°C. Note that the probe remained hybridized to ANG BamHI j fragment at 60°C but is removed at 65°C . The probe remained hybridized to the BamHI j fragment derived from ANG path and viruses 33LB1, 33LC2, and 3901D at both temperatures. Neuroinvasive viruses are shown (NI+) . 33LC2, and 3901D) demonstrate LDsos that range from 106 to 108 PFU. The genotypes of these agents were established by stringent Southern hybridization . An oligodeoxynucleotide probe predicted to be specific for the ANG path gD gene (see legend to Fig. 10 ) was synthesized and then hybridized to Southern blotted DNA derived from the various isolates. Under appropriate hybridization stringency (Fig. 10, 65°C ), this probe can distinguish the gD-encoding ANG path BamHI j fragment from ANG BamHI j fragment. By comparison, the probe reveals no difference under reduced hybridization stringency (Fig. 10, 60°C ). Neuroinvasive agents recovered from the brains of mice killed by infection with virus generated by ANG DNA co-transfection with the ANG path HindIII/NarI fragment (33LB1, 33LC2, and 3901D) hybridize to the probe similar to ANG path. The simplest interpretation of these results is that these neuroinvasive agents possess the same coding sequence as the ANG path gD gene. Taken together, these results indicate that the defect in ANG maps to nucleotide number 138,744 in the HSV1 sequence (18, 19) and amino acid position 84 in glycoprotein D. This predicts that an alanine in the ANG gD protein becomes glycine in the ANG path gD protein.
Discussion
We have employed HSV1 ANG (4, 5), a strain that does not cause lethal neurologic disease in mice following infection on rear footpads, and ANG path, a fully lethal brainpassaged derivative of ANG, to show that this phenotypic difference is related to a gene that specifically effects virus entrance into the nervous system. Marker rescue experiments utilizing cloned ANG path genes to confer neuroinvasiveness on ANG revealed that the gene that codes for gD is responsible for this phenotypic difference. When ANG and ANG path gD genes were sequenced, a single nucleotide difference predicted to change an alanine to glycine at amino acid number 84 in the mature protein was noted. Using these data, an oligodeoxynucleotide probe was prepared and employed in Southern blot analysis to demonstrate that neuroinvasive agents derived by marker rescue encode that base change seen in the ANG path gD gene. From these results, we conclude that HSV1 gD protein functions in vivo to effect neuroinvasiveness, and that gD amino acid 84 is critical to this process.
Before speculating on the potential mechanisms by which a change in the primary amino acid sequence of gD could alter neuroinvasiveness, it is important to summarize potentially relevant properties of this protein. gD lies on the surface ofthe virion and is anchored to the envelope at the COOH terminus . The mature protein is 369 amino acids long, it has three potential Winked glycosylation sites, it is synthesized both early and late during the viral replication cycle, and it is translated between short unique segment nucleotides 138,419 to 139,601 from an unspliced 2.8-kb polyadenylated transcript (16-19) . The predicted amino acid difference between the ANG gD (position 84 alanine) and the ANG path gD (position 84 glycine) lies in a region that may be ot-helical. This sec- 49 4 Herpes Simplex Virus Type 1 Neuroinvasiveness ondary structure is further predicted to lie in an exposed reverse turn domain that contains an N-linked glycosylated amino acid (20, 21) . The predicted alteration in the primary amino acid sequence of ANG gD could potentially affect neuroinvasiveness through two mechanisms. Since the ANG invasion is restricted in the footpad because of reduced virus entry into the nervous system and since gD protein performs an essential function in virus replication to facilitate virion penetration into cells (22, 23), it could be hypothesized that the alteration in the ANG gD induces a structural change in the protein that may lead to less efficient virion penetration into nerve terminals in the footpad. Such a phenomenon could also be a property ofnerve terminals between the peripheral and central nervous systems. This change may be specific for nerve terminals as opposed to neuron somas since ANG replicates efficiently in the mouse brain where neuron somas are accessible to infection. The anatomic separation ofneuron soma and nerve terminals in vivo, which is required to examine this hypothesis, can be reproduced in vitro using Campenot chambers to culture dissociated spinal dorsal root ganglia (24). Such a system may help to address the question of altered viral penetration ofnerve terminals that may be caused by the predicted change in the ANG gD protein.
The second mechanism that may be responsible for the reduced entry of ANG into the nervous system relates to immunologic phenomena. Many investigations have shown that gD protein stimulates production ofprotective antibody and possibly cytotoxic T cells and is a major neutralizable herpes antigen (25-30) . Therefore, the ANG gD protein could be more immunogenic or render the virion more susceptible to restriction by adaptive immunity than the ANG path gD protein. Mechanisms involving immune restriction of viral invasion would predict that ANG and ANG path viruses demonstrate similar capacity to induce lethal neurologic disease in immune-suppressed mice following rear footpad inoculation.
Finally, since replacement with ANG path gD gene sequences did not fully rescue ANG to the PFU/LDso ratio demonstrated'by ANG path, it seems likely that another gene in addition to the gD gene is involved in the reduced neuroinvasiveness phenotype of ANG. In this regard, since the recombinants generated with the ANG path gD gene are at least 10 times less neuroinvasive than ANG path, a second gene probably would function to a minor degree and might function only in concert with ANG path gD gene. It is possible that the ANG path gD x ANG recombinant viruses produced here (strains 33LB1, 33LC2, or 3901D) could be used in marker rescue experiments to identify other genes involved with the reduced neuroinvasiveness ofANG . As one possibility, since HSV glycoproteins function together (31) and since it is likely that gD protein interacts with other glycoproteins in the envelope, marker rescue with genes encoding an ANG path glycoprotein and ANG path gD gene might reveal the full potential neuroinvasiveness .
In summary, we have used biological and genetic methods to show that HSV1 neuroinvasiveness is, in part, a function of gD. Since this protein is well characterized, continued investigation of this system is likely to lead to additional in-
